OnKure Therapeutics, Inc. OKUR Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by OnKure Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- OnKure Therapeutics, Inc. (OKUR) reported operating lease right-of-use assets in other assets of $288K in Q1 2026.
- How has OnKure Therapeutics, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- OnKure Therapeutics, Inc.'s operating lease right-of-use assets in other assets decreased by 57.4% year-over-year, from $676K to $288K.
- What is the long-term trend for OnKure Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Over 3 years (2022 to 2025), OnKure Therapeutics, Inc.'s operating lease right-of-use assets in other assets has grown at a -33.1% compound annual growth rate (CAGR), from $1.29M to $387K.